IBEX
IBEX Limited
IBEX has lower modeled downside risk, despite its lower overall score.
INTC
Intel Corporation
INTC has the edge over IBEX overall, supported by stronger modeled upside and stronger valuation.
IBEX Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Strong |
IBEX's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
INTC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Healthy | |
| Healthy |
INTC's revenue, cash flow and balance sheet are currently healthy, but its profitability is under pressure.
IBEX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 10x | $33.48 | -39% |
| Fair | 13x | $42.92 | -22% |
| Forward | 14x | $54.87 | — |
| Current | 17x | $54.87 | — |
| Expensive | 20x | $66.14 | +21% |
Historical ranges are pointers, not guarantees.
IBEX's PE is in its expensive range at 17x. If earnings grow as analysts expect, today's price would be 14x next year's earnings, in its fair range.
INTC PE Valuation
INTC has no meaningful PE right now: it lost money over the past year.
IBEX Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for IBEX, with profitability holding steady.
INTC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Broad | |
| Low |
INTC has the edge over IBEX on the outlook, with more favorable profitability expectations.
IBEX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.95 | +20% |
| Q3 2026 | $3.30 | +20% |
| Q2 2026 | $3.13 | +33% |
| Q1 2026 | $3.17 | +39% |
| Q4 2025 | $3.01 | +42% |
| Q3 2025 | $2.75 | +46% |
| Q2 2025 | $2.36 | +28% |
| Q1 2025 | $2.28 | +49% |
| Q4 2024 | $2.12 | +35% |
IBEX has the edge over INTC on earnings quality, reporting a profit while its opponent remains loss making.
INTC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.41 | — |
| Q3 2026 | -$2.39 | -24000% |
| Q2 2026 | -$2.09 | +$2.68 |
| Q1 2026 | -$0.60 | +$3.88 |
| Q4 2025 | -$0.06 | +$4.32 |
| Q3 2025 | $0.01 | +$3.72 |
| Q2 2025 | -$4.77 | -2088% |
| Q1 2025 | -$4.48 | -562% |
| Q4 2024 | -$4.38 | -1195% |
INTC has swung to a loss: it lost $2.39 per share over the past year, after a profit the year before.
IBEX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $175.2M | +16% |
| Q2 2026 | $164.3M | +12% |
| Q1 2026 | $164.4M | +17% |
| Q4 2025 | $164.2M | +17% |
| Q3 2025 | $151.2M | +17% |
| Q2 2025 | $147.1M | +18% |
| Q1 2025 | $140.7M | +11% |
| Q4 2024 | $140.7M | +6.1% |
IBEX has the edge over INTC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 10% | +1.4 points |
| Q2 2026 | 6% | -2.3 points |
| Q1 2026 | 9.8% | +0.4 points |
| Q4 2025 | 9.3% | +0.8 points |
| Q3 2025 | 9.1% | +2.1 points |
| Q2 2025 | 8.3% | -2 points |
| Q1 2025 | 9.5% | +0.6 points |
| Q4 2024 | 8.5% | +3.2 points |
IBEX's operating margin was 10% last quarter, up 1.4 points from the same quarter a year ago, near the top of its range since 2019.
INTC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $16.5B | +21% |
| Q2 2026 | $16.1B | +25% |
| Q1 2026 | $13.6B | +7.2% |
| Q4 2025 | $13.7B | -4.1% |
| Q3 2025 | $13.7B | +2.8% |
| Q2 2025 | $12.9B | +0.2% |
| Q1 2025 | $12.7B | -0.4% |
| Q4 2024 | $14.3B | -7.4% |
INTC's revenue is recovering but still below its 2021 peak: $16.5B last quarter, up 21% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +10 points |
| Q2 2026 | 11% | +36 points |
| Q1 2026 | -23% | -21 points |
| Q4 2025 | 4.2% | +1.4 points |
| Q3 2025 | 5% | +73 points |
| Q2 2025 | -25% | -9.4 points |
| Q1 2025 | -2.4% | +6 points |
| Q4 2024 | 2.9% | -14 points |
INTC has the edge over IBEX on profitability, with a higher operating margin.
IBEX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $9.2M | +14% |
| Q2 2026 | $21.7M | -4.9% |
| Q1 2026 | $6.6M | +85% |
| Q4 2025 | -$5.1M | -$1.9M |
| Q3 2025 | $8M | +94% |
| Q2 2025 | $22.8M | +50% |
| Q1 2025 | $3.6M | -63% |
| Q4 2024 | -$3.2M | +$1.4M |
IBEX still generates free cash flow, though less than at its 2022 peak: $32M over the past year.
INTC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +774% |
| Q2 2026 | $4.5B | +$6B |
| Q1 2026 | -$2.5B | +$1.8B |
| Q4 2025 | $800M | +$3.5B |
| Q3 2025 | $121M | +$2.5B |
| Q2 2025 | -$1.5B | +$1.9B |
| Q1 2025 | -$4.4B | +$2.8B |
| Q4 2024 | -$2.7B | -$597M |
INTC has the edge over IBEX on cash flow, with more consistent year-over-year improvement.
IBEX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.3% | +187K shares |
| 1 year | +2.6% | +386K shares |
| 3 years | -21% | -3.9M shares |
| 5 years | -21% | -3.9M shares |
| Available history | -15% | -2.7M shares |
IBEX has the edge over INTC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.5M |
| Q2 2026 | $4.2M |
| Q1 2026 | $4.6M |
| Q4 2025 | $2.8M |
| Q3 2025 | $2.8M |
| Q2 2025 | $1.6M |
| Q1 2025 | $25.1M |
| Q4 2024 | $46.6M |
IBEX spent $16M buying back its own shares over the past year, down 79% from the year before.
INTC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4% | +203M shares |
| 1 year | +17% | +776M shares |
| 3 years | +25% | +1.1B shares |
| 5 years | +30% | +1.2B shares |
| Available history | +19% | +834M shares |
INTC has 5.3B diluted shares, up 17% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | $114M |
| Q1 2021 | $2.3B |
IBEX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.4x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.2x | Net Cash |
| Q4 2025 | -0.2x | Net Cash |
| Q3 2025 | -0.3x | Net Cash |
| Q2 2025 | -0.2x | Net Cash |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | -0.2x | Net Cash |
IBEX has the edge over INTC on leverage, with a lower net debt burden relative to earnings.
INTC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.0x | Healthy |
| Q2 2026 | 3.1x | Elevated |
| Q1 2026 | 3.9x | Elevated |
| Q4 2025 | 3.4x | Elevated |
| Q3 2025 | 4.0x | Elevated |
| Q1 2025 | 69.6x | High |
| Q3 2024 | 23.8x | High |
| Q2 2024 | 4.3x | High |
INTC's net debt is about 2.0 years of its operating earnings (EBITDA), down from 4.0 years a year ago.
IBEX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 78.3 | Overbought |
| Stochastic | 91.0 | Overbought |
IBEX's weekly RSI is 78 (overbought) and its Stochastic is 91 (overbought).
INTC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.1 | Neutral |
| Stochastic | 7.7 | Oversold |
INTC's weekly RSI is 38 (neutral) and its Stochastic is 8 (oversold).
IBEX PE vs Technology Sector
| Metric | IBEX | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 28x | 40% below |
| PE % | 73 | 37 | 36 pts above |
IBEX is trading at 17x earnings, a 40% discount to the Technology sector's median of 28x.
INTC PE vs Technology Sector
| Metric | INTC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
INTC has no meaningful PE right now: it lost money over the past year.
IBEX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $46.8 | 17% above |
| 20 week MA | $40.6 | 35% above |
| 50 week MA | $35.5 | 54% above |
| 100 week MA | $32.3 | 70% above |
| 200 week MA | $25.5 | 115% above |
IBEX has the edge over INTC on trend strength, trading above more of its moving averages.
INTC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $88.4 | 31% below |
| 20 week MA | $95.3 | 36% below |
| 50 week MA | $79.3 | 23% below |
| 100 week MA | $52.1 | 18% above |
| 200 week MA | $42.5 | 44% above |
INTC has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 44% above its 200-week average.
IBEX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15.4 | $20.1 | +30% |
| 2021 | $20.1 | $13.9 | -31% |
| 2022 | $13.9 | $25.6 | +84% |
| 2023 | $25.6 | $19.0 | -26% |
| 2024 | $19.0 | $21.4 | +13% |
| 2025 | $21.4 | $38.5 | +80% |
| 2026 YTD | $38.5 | $54.9 | +43% |
IBEX has finished higher in four of the last six years, two of them by more than 50%. It's up 43% so far in 2026.
INTC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $60.1 | $47.1 | -22% |
| 2021 | $47.1 | $51.3 | +9% |
| 2022 | $51.3 | $26.1 | -49% |
| 2023 | $26.1 | $50.3 | +93% |
| 2024 | $50.3 | $20.3 | -60% |
| 2025 | $20.3 | $36.2 | +78% |
| 2026 YTD | $36.2 | $61.2 | +69% |
INTC has the edge over IBEX on returns for 2026, with the stronger performance.